SCHEMBL16596179

SCHEMBL16596179

CCCCCCCCCCCC(=O)Nc1cc(C)nc2ccccc12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.71
KDM4E B2RXH2 4/20 0.71
GAA P10253 3/20 0.71
HPGD P15428 3/20 0.71
TSHR P16473 2/20 0.71
HSD17B10 Q99714 2/20 0.71
GLA P06280 1/20 0.71
MAPK1 P28482 1/20 0.71
HTT P42858 3/20 0.65
RAB9A P51151 3/20 0.65
SMN1; SMN2 Q16637 3/20 0.65
GALR3 O60755 1/20 0.65
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
EP300 Q09472 1/20 0.56
OPRK1 P41145 1/20 0.56
SOAT1 P35610 2/20 0.54
SPHK2 Q9NRA0 1/20 0.53
SPHK1 Q9NYA1 1/20 0.53
CETP P11597 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18332920 0.95 ALDH1A1 (0.72) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL19308467 0.91 HTT (0.73) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL17817438 0.84 KDM4E (0.98) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL8402836 0.84 HTT (0.75) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL5459383 0.83 HDAC6 (0.59) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL4872495 0.80 HTT (0.73) ALDH1A1KDM4EHTTRAB9ASMN1; SMN2
SCHEMBL10113820 0.80 HTT (0.56) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL10113547 0.80 HTT (0.56) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL27476154 0.79 ALDH1A1 (0.60) ALDH1A1KDM4EGAAHPGDTSHR
SCHEMBL17816977 0.78 GAA (0.73) ALDH1A1KDM4EGAAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
WO-2015042363-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES BLVRB, PGLS, GRHPR ALDH1A1 4735/4885KDM4E 3795/4885GAA 2836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.